These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 6148006)
1. The decrease in coronary heart disease mortality. Status and perspectives on the role of cholesterol. Am J Cardiol; 1984 Aug; 54(5):35C-41C. PubMed ID: 6148006 [No Abstract] [Full Text] [Related]
2. Therapy of familial and acquired hyperlipoproteinemia in children and adolescents. Glueck CJ Prev Med; 1983 Nov; 12(6):835-47. PubMed ID: 6676731 [No Abstract] [Full Text] [Related]
7. Lipid lowering effects on cardiovascular morbidity and mortality. Clinical evidence and therapeutic guidelines. Islami Y; Ribeiro LG Arq Bras Cardiol; 1988 Jul; 51(1):43-8. PubMed ID: 3073735 [No Abstract] [Full Text] [Related]
8. LRC-CPP trial. Johnstone JR Med J Aust; 1984 Jun; 140(12):739. PubMed ID: 6727739 [No Abstract] [Full Text] [Related]
9. [Cholestyramine in the treatment of hypercholesterolemia. Our experience in 11 cases]. Maíz A; Arteaga A; Villanueva CL; Velasco N; Acosta AM Rev Med Chil; 1990 Sep; 118(9):1009-13. PubMed ID: 2152729 [TBL] [Abstract][Full Text] [Related]
10. Comparison of hypocholesterolemic activities of the bile acid sequestrants cholestyramine and colestipol hydrochloride in cholesterol fed SEA quail. Day CE Artery; 1990; 17(5):281-8. PubMed ID: 2396902 [TBL] [Abstract][Full Text] [Related]
15. [Vasosan S--a cholestyramine in the treatment of hypercholesterolemia of various etiopathogenesis]. Kolesár P Vnitr Lek; 1994 Feb; 40(2):89-92. PubMed ID: 8140767 [TBL] [Abstract][Full Text] [Related]
16. [Significance of hypercholesterolemia for epidemiology, prevention and pathogenesis of coronary heart diseases]. Gohlke H Dtsch Med Wochenschr; 1989 Dec; 114(50):1974-8. PubMed ID: 2689125 [No Abstract] [Full Text] [Related]
17. Control of biochemical precursors of coronary heart disease. Ostrander LD Geriatrics; 1969 Dec; 24(12):61-6. PubMed ID: 5353631 [No Abstract] [Full Text] [Related]
18. Therapy of familial hypercholesterolemia in childhood: diet and cholestyramine resin for 24 to 36 months. Glueck CJ; Tsang RC; Fallat RW; Mellies M Pediatrics; 1977 Mar; 59(3):433-41. PubMed ID: 840563 [TBL] [Abstract][Full Text] [Related]
19. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia]. Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G Therapie; 1978; 33(5):615-22. PubMed ID: 217121 [No Abstract] [Full Text] [Related]
20. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II. Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]